| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | name | dosage / volume / unit of measurement | unit of measurement | Quantity | ||||||||||||||||||||||
2 | Blood | |||||||||||||||||||||||||
3 | Cryoprecipitate | doses | doses | 250 | ||||||||||||||||||||||
4 | Red blood cells | doses | doses | 250 | ||||||||||||||||||||||
5 | (Fresh-frozen plasma) | doses | doses | 250 | ||||||||||||||||||||||
6 | (Tranexamic acid) | injection: 50 mg / ml in an ampoule | amp | 250 | ||||||||||||||||||||||
7 | (Tranexamic acid) | 100 mg / ml in ampoules | amp | 250 | ||||||||||||||||||||||
8 | Heparin sodium | injections: 5000 IU / ml | vials | 250 | ||||||||||||||||||||||
9 | Hydroxyethylstarch | 6% infusion solution (60 mg / ml) | ml | 250 | ||||||||||||||||||||||
10 | Hydroxyethylstarch | 10% solution for infusion (100 mg / ml) | ml | 250 | ||||||||||||||||||||||
11 | (Enoxaparin) | 20 mg / 0.2 ml; | ml | 250 | ||||||||||||||||||||||
12 | (Enoxaparin) | 40 mg / 0.4 ml; | ml | 250 | ||||||||||||||||||||||
13 | (Enoxaparin) | 100 mg / 1 ml; | ml | 250 | ||||||||||||||||||||||
14 | (Enoxaparin) | 150 mg / 1 ml | ml | 250 | ||||||||||||||||||||||
15 | Antihistamines | |||||||||||||||||||||||||
16 | Chlorpyramine | 20 mg / ml 1 ml | amp | 250 | ||||||||||||||||||||||
17 | Mebhydrolin | 0,05g | tab | 100 | ||||||||||||||||||||||
18 | Chloropyramine | 25mg | tab | 100 | ||||||||||||||||||||||
19 | Desloratadine | Syrup 1 ml/0.5 mg | syrup | 100 | ||||||||||||||||||||||
20 | Loratadine | 10 mg | tab | 100 | ||||||||||||||||||||||
21 | Mineral additives. Buffer bases. Electrolytes. Haemostatics | |||||||||||||||||||||||||
22 | Tranexamic acid | 500mg | tab | 250 | ||||||||||||||||||||||
23 | Aminocaproic acid | 5% 100ml | bottle | 250 | ||||||||||||||||||||||
24 | (Calcium gluconate) | 100 mg / ml 10 ml | amp | 250 | ||||||||||||||||||||||
25 | Aqua pro injectionibus/Water for injection) | solution for injection: 2 ml in ampoules | amp | 500 | ||||||||||||||||||||||
26 | (Aqua pro injectionibus/Water for injection) | solution for injection: 5 ml in ampoules | amp | 500 | ||||||||||||||||||||||
27 | Aqua pro injectionibus/Water for injection) | solution for injection: 10 ml in ampoules | amp | 500 | ||||||||||||||||||||||
28 | Sodium lactate), complex solution of Sodium chloride + Potassium chloride + Calcium chloride + Sodium lactate) | injection of 100 U / ml and 5 ml; 10 ml in a bottle | ml | 250 | ||||||||||||||||||||||
29 | (Potassium chloride) | 4% | vials | 250 | ||||||||||||||||||||||
30 | Potassium chloride) | 7,50% | vials | 250 | ||||||||||||||||||||||
31 | Sodium lactate), complex solution of Sodium chloride + Potassium chloride + Calcium chloride + Sodium lactate) | injection of 100 U / ml and 5 ml; 10 ml in a bottle | ml | 250 | ||||||||||||||||||||||
32 | Complex solution of Sodium chloride + Potassium chloride + Calcium chloride | solution for infusion | ml | 250 | ||||||||||||||||||||||
33 | Peripheral Parenteral Nutrition | solution for infusion | ml | 500 | ||||||||||||||||||||||
34 | Sodium chloride) | solution for injection / infusion: 0.9% isotonic (equivalent to Na + 154 mmol / l, Cl - 154 mmol / l) | ml, soft pack | 1000 | ||||||||||||||||||||||
35 | Sodium hydrogen carbonate) | injection: 1,4 % - 8,4 % | ml | 250 | ||||||||||||||||||||||
36 | Antibiotics | |||||||||||||||||||||||||
37 | (Clindamycin) | capsules: 150 mg (as hydrochloride) | tab | 100 | ||||||||||||||||||||||
38 | (Clindamycin) | solution for oral use: 75 mg / 5 ml (palmitate) | vials | 50 | ||||||||||||||||||||||
39 | (Clindamycin) | injection: 150 mg (as phosphate) / ml | amp | 300 | ||||||||||||||||||||||
40 | (Gentamicin) | injections: 10 mg (as sulphate) / ml in 2 ml ampoules; | amp | 100 | ||||||||||||||||||||||
41 | (Gentamicin) | injections: 40 mg (as sulphate) / ml in 2 ml ampoules; | amp | 100 | ||||||||||||||||||||||
42 | (Chloramphenicol) | solid oral dosage form: 250 mg | tab | 50 | ||||||||||||||||||||||
43 | (Chloramphenicol) | solid oral dosage form: 500 mg | tab | 50 | ||||||||||||||||||||||
44 | (Chloramphenicol) | oil suspension for injection *: 0.5 g (as sodium succinate) / ml in 2 ml ampoules | amp | 100 | ||||||||||||||||||||||
45 | (Chloramphenicol) | solution for oral use: 150 mg (as palmitate) / 5 ml | vials | 50 | ||||||||||||||||||||||
46 | (Chloramphenicol) | powder for solution for injection: 0.5 g (sodium succinate) per vial | vials | 50 | ||||||||||||||||||||||
47 | (Chloramphenicol) | powder for solution for injection: 1 g (sodium succinate) in a vial | vials | 50 | ||||||||||||||||||||||
48 | (Cefepime) | powder for solution for injection: 1000 mg; | vials | 100 | ||||||||||||||||||||||
49 | (Cefepime) | powder for solution for injection: 500 mg; | vials | 50 | ||||||||||||||||||||||
50 | (Cefepime) | powder for solution for injection: 2000 mg; | vials | 50 | ||||||||||||||||||||||
51 | (Meropenem) | powder for injection / infusion: 1 g (as trihydrate) | vials | 50 | ||||||||||||||||||||||
52 | (Meropenem) | powder for injection / infusion: 500 mg (as trihydrate); 1 g (as trihydrate) | vials | 100 | ||||||||||||||||||||||
53 | ||||||||||||||||||||||||||
54 | (lmipenem + Cilastatin) | powder for solution for injection: 500 mg (as monohydrate) + 500 mg (as sodium salt) in vials | vials | 50 | ||||||||||||||||||||||
55 | (lmipenem + Cilastatin) | powder for solution for injection: 250 mg (as monohydrate) + 250 mg (as sodium salt) in vials | vials | 50 | ||||||||||||||||||||||
56 | (Cefotaxime) | powder for solution for injection: 1000 mg (as sodium salt) in a vial | vials | 50 | ||||||||||||||||||||||
57 | (Cefotaxime) | powder for solution for injection: 250 mg (as sodium salt) in a vial | vials | 50 | ||||||||||||||||||||||
58 | (Cefotaxime) | powder for solution for injection: 500 mg (as sodium salt) in a vial | vials | 50 | ||||||||||||||||||||||
59 | (Piperacillin and enzyme inhibitor) | powder for injection: 2 g (as sodium salt) + 250 mg (as sodium salt) | vials | 50 | ||||||||||||||||||||||
60 | (Piperacillin and enzyme inhibitor) | powder for injection: 4 g (as sodium salt) + 500 mg (as sodium salt) | vials | 50 | ||||||||||||||||||||||
61 | Amoxicillin + Clavulanic acid) | tablets: 500 mg / 125 mg; | tab | 250 | ||||||||||||||||||||||
62 | Amoxicillin + Clavulanic acid) | powder for injection: 1000 mg + 200 mg | vials | 50 | ||||||||||||||||||||||
63 | Amoxicillin + Clavulanic acid) | oral solution: 125 mg amoxicillin + 31.25 mg clavulanic acid / 5 ml | vials | 50 | ||||||||||||||||||||||
64 | (Amoxicillin + Clavulanic acid) | tablets: 250 mg / 62.5 mg; | tab | 250 | ||||||||||||||||||||||
65 | (Amoxicillin + Clavulanic acid) | powder for injection: 500 mg + 100 mg | vials | 50 | ||||||||||||||||||||||
66 | Chloramphenicol | eye oinment 20 gr | eye oinment | 50 | ||||||||||||||||||||||
67 | Nifuroxazidum | 100mg | tab | 250 | ||||||||||||||||||||||
68 | (Vancomycin) | powder for solution for injection: 1000 mg (hydrochloride) in a vial | vials | 50 | ||||||||||||||||||||||
69 | (Vancomycin) | powder for solution for injection: 250 mg (hydrochloride) in a vial | vials | 50 | ||||||||||||||||||||||
70 | (Vancomycin) | powder for solution for injection: 500 mg (hydrochloride) in a vial | vials | 50 | ||||||||||||||||||||||
71 | (Vancomycin) | lyophilisate for solution for infusion: 500 mg per vial | vials | 50 | ||||||||||||||||||||||
72 | (Vancomycin) | lyophilisate for solution for infusion: 1000 mg per vial | vials | 50 | ||||||||||||||||||||||
73 | (Ciprofloxacin) | solution for intravenous infusion: 2 mg / ml (as hyclate) | vials | 50 | ||||||||||||||||||||||
74 | (Ciprofloxacin) | tablets: 500 mg (as hydrochloride) | tab | 250 | ||||||||||||||||||||||
75 | (Ciprofloxacin) | solution for oral use: 250 mg / 5 ml (anhydrous) | vials | 50 | ||||||||||||||||||||||
76 | (Ciprofloxacin) | tablets: 250 mg (as hydrochloride) | tab | 250 | ||||||||||||||||||||||
77 | Levofloxacin | solution 5mg/ml;100ml | solution | 50 | ||||||||||||||||||||||
78 | Avelox | 400 mg/250 ml | solution | 50 | ||||||||||||||||||||||
79 | (Azithromycin) | solid oral dosage form: 500 mg | tab | 250 | ||||||||||||||||||||||
80 | (Azithromycin) | solution for oral use: 200 mg / 5 ml | vials | 50 | ||||||||||||||||||||||
81 | (Azithromycin) | solid oral dosage form: 250 mg; | tab | 250 | ||||||||||||||||||||||
82 | (Azithromycin) | powder for oral suspension: 100 mg / 5 ml; | vials | 50 | ||||||||||||||||||||||
83 | (Azithromycin) | powder for oral suspension: 200 mg / 5 ml; | vials | 50 | ||||||||||||||||||||||
84 | (Linezolid) | solution for infusion: 2 mg / ml of 300 ml | pack | 50 | ||||||||||||||||||||||
85 | (Linezolid) | powder for oral liquid: 100 mg / 5 ml | vials | 50 | ||||||||||||||||||||||
86 | (Linezolid) | tablets: 400 mg; | tab | 250 | ||||||||||||||||||||||
87 | (Linezolid) | tablets: 600 mg | tab | 250 | ||||||||||||||||||||||
88 | (Daptomycin) | powder for concentrate for solution for infusion: 500 mg | vials | 50 | ||||||||||||||||||||||
89 | (Daptomycin) | powder for solution for infusion: 500 mg | vials | 50 | ||||||||||||||||||||||
90 | (Daptomycin) | powder for concentrate for solution for infusion: 350 mg | vials | 50 | ||||||||||||||||||||||
91 | (Ceftriaxone) | powder for solution for injection: 1 g (as sodium salt) in a vial | vials | 50 | ||||||||||||||||||||||
92 | (Ceftriaxone) | powder for solution for injection: 250 mg (as sodium salt) in a vial | vials | 50 | ||||||||||||||||||||||
93 | (Ceftriaxone) | powder for solution for injection: 500 mg (as sodium salt) in a vial | vials | 50 | ||||||||||||||||||||||
94 | (Erythromycin) | solid oral dosage form: 200 mg; | tab | 250 | ||||||||||||||||||||||
95 | (Erythromycin) | solid oral dosage form: 250 mg; | tab | 250 | ||||||||||||||||||||||
96 | (Erythromycin) | 125 mg / 5 ml (as stearate or estolate or ethyl succinate) | vials | 50 | ||||||||||||||||||||||
97 | (Erythromycin) | powder for solution for injection: 500 mg (as lactobionate) in a vial | vials | 50 | ||||||||||||||||||||||
98 | Antifungal | |||||||||||||||||||||||||
99 | (Flucytosine) | solution for infusion: 2.5 g / 250 ml | amp | 250 | ||||||||||||||||||||||
100 | (Flucytosine) | capsules: 250 mg | tab | 250 | ||||||||||||||||||||||